Profiling peripheral microRNAs in obesity and type 2 diabetes mellitus.
Mechanisms of type 2 diabetes mellitus (T2DM) remain elusive, in which obesity (OB) is considered as one of the major risk factors for the disease. A microRNA (miRNA) is a small non-coding RNA molecule functioning in RNA silencing and post-transcriptional regulation of gene expression. It has been demonstrated that some miRNAs can exist in serum stably and is closely related to various diseases. The goal of our study was to identify whether the deregulation of serum miRNAs was associated with T2DM and obesity. Twenty-five subjects with T2DM2, 25 healthy controls, 25 subjects with obesity, and 25 subjects with T2DM combined with obesity were included in the study. A total of 536 miRNA serum samples from these four groups were studied by miRNA polymerase chain reaction (PCR) panels. Data showed that miR-152 and miR-17 were significantly elevated in the OB group, whereas miR-138 was significantly decreased in OB group when compared to controls, T2DM, or T2DM+obesity group. In addition, level of MiR-593 was significantly lower in T2DM group and T2DM+obesity group when compared with controls. Further analysis revealed that the four miRNAs can be used as potential biomarkers to distinguish obesity from T2DM, OB+T2DM, and healthy subjects. Our study is one of the pioneer studies showing the differences in peripheral miRNA level in obesity, T2DM and T2DM combined with obesity. The study results suggest the potential utility of miRNAs in the prediction for obesity and T2DM.
Surgical Center of Thyroid Diabetes, General Hospital of Guangzhou Military Command of PLA, Guangzhou, China.
Liangping
L
Wu
Surgical Center of Thyroid Diabetes, General Hospital of Guangzhou Military Command of PLA, Guangzhou, China.
Xiaojiang
X
Dai
Health Management Center, Guangzhou First People's Hospital, Guangzhou Medical College, Guangzhou, China.
Junfang
J
Zhan
Surgical Center of Thyroid Diabetes, General Hospital of Guangzhou Military Command of PLA, Guangzhou, China.
Yuxin
Y
Zhang
Surgical Center of Thyroid Diabetes, General Hospital of Guangzhou Military Command of PLA, Guangzhou, China.
Hongbin
H
Zhang
Surgical Center of Thyroid Diabetes, General Hospital of Guangzhou Military Command of PLA, Guangzhou, China.
Hongbing
H
Zhang
Surgical Center of Thyroid Diabetes, General Hospital of Guangzhou Military Command of PLA, Guangzhou, China.
Songhua
S
Zeng
Surgical Center of Thyroid Diabetes, General Hospital of Guangzhou Military Command of PLA, Guangzhou, China.
Wenbin
W
Xi
D000328:Adult; D015415:Biomarkers / Q000097:blood; D001786:Blood Glucose / Q000378:metabolism; D015992:Body Mass Index; D016022:Case-Control Studies; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000235:genetics*; D020869:Gene Expression Profiling; D005786:Gene Expression Regulation; D064368:Healthy Volunteers; D006801:Humans; D007328:Insulin / Q000097:blood; D035683:MicroRNAs / Q000097:blood* / Q000235:genetics; D008875:Middle Aged; D009765:Obesity / Q000097:blood / Q000235:genetics*; D012307:Risk Factors
D015415:Biomarkers; D001786:Blood Glucose; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D007328:Insulin; C546110:MIRN138 microRNA, human; C550856:MIRN152 microRNA, human; C524941:MIRN17 microRNA, human; C577650:MIRN593 microRNA, human; D035683:MicroRNAs
MicroRNA; diabetes; obesity